Massive Fetomaternal Hemorrhage Remote from Term: Favorable Outcome after Fetal Resuscitation and Conservative Management.

Decreased fetal movement Fetal anemia Fetal blood sampling Fetal blood transfusion Fetal hydrops Fetal thrombocytopenia Fetomaternal hemorrhage Middle cerebral artery peak systolic velocity

Journal

Fetal diagnosis and therapy
ISSN: 1421-9964
Titre abrégé: Fetal Diagn Ther
Pays: Switzerland
ID NLM: 9107463

Informations de publication

Date de publication:
2019
Historique:
received: 22 03 2018
accepted: 06 08 2018
pubmed: 11 9 2018
medline: 18 12 2019
entrez: 11 9 2018
Statut: ppublish

Résumé

Fetomaternal hemorrhage (FMH) is a rare condition that requires early diagnosis and appropriate treatment due to its potentially severe consequences. We report a case of massive FMH presenting as decreased fetal movement, fetal hydrops, and intracranial hemorrhage at 24 weeks. Treatment considerations were made and amniocentesis, fetal blood sampling, and fetal blood transfusion via cordocentesis were performed. Recurrent FMH required subsequent fetal transfusion 2 days later. Surveillance was continued twice weekly until the patient delivered a viable infant at 38 weeks after spontaneous labor. Recurrent FMH was unpredictable due to its unclear etiology and absence of precipitating events, however close surveillance proved effective.

Identifiants

pubmed: 30199875
pii: 000492750
doi: 10.1159/000492750
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

361-364

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Maria Flavia Christino Luiz (MF)

Faculdade de Ciencias Medicas de Santos, Centro Universitario Lusiada, Santos, Brazil.

Ahmet A Baschat (AA)

Center for Fetal Therapy, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Cassandra Delp (C)

Center for Fetal Therapy, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Jena L Miller (JL)

Center for Fetal Therapy, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, jmill260@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH